{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:02:49Z","timestamp":1783036969414,"version":"3.54.6"},"reference-count":216,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI137425"],"award-info":[{"award-number":["R01AI137425"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Lyme disease is the most prevalent tick-borne infection caused by <jats:italic>Borrelia burgdorferi<\/jats:italic> bacteria in North America. Other Borrelia species are predominately the cause of this disease in Eurasia with some distinct and various overlapping manifestations. Consequently, caution must be exercised when comparing the disease and its manifestations and treatment regimens in North America and Europe. Diagnosis of the early Lyme disease remains difficult using the currently FDA approved serological tests in the absence of a reported tick bite or of erythema migrans in many individuals, non-specific initial symptoms, and the absence of detectable anti-Borrelia antibodies in the prepatent period of infection. Furthermore, it is difficult to distinguish persistence of infection and disease versus reinfection in the endemic regions of Lyme disease by serological assays. If early infection remains untreated, spirochetes can disseminate and could affect various organs in the body with a variety of disease manifestations including arthralgias and musculoskeletal pain, neurologic symptoms and anomalies, and acrodermatitis chronicum atrophicans (ACA) in Europe. Although most patients recover after antibiotic treatment, an estimated \u223c10\u201320% patients in the United States show persistence of symptoms known as post-treatment Lyme disease syndrome (PTLDS). The causes and biomarkers of PTLDS are not well-defined; however, several contributing factors with inconsistent degree of supporting evidence have been suggested. These include antigenic debris, dysregulation of immunological response, bacterial persisters, or combination of these features. This review highlights currently employed treatment approaches describing different antimicrobials used, and vaccine candidates tried to prevent <jats:italic>B. burgdorferi<\/jats:italic> infection.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1459202","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:55:03Z","timestamp":1726203303000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms"],"prefix":"10.3389","volume":"15","author":[{"given":"Kashaf","family":"Zafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyedikachi C.","family":"Azuama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhat","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"B1","article-title":"Acupuncture and Chinese herbs relieve long-term symptoms of lyme disease: A case report.","volume":"2","author":"Adams","year":"2023","journal-title":"Converg. Points"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116767","article-title":"Health care costs, utilization and patterns of care following Lyme disease.","volume":"10","author":"Adrion","year":"2015","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1128\/AAC.36.8.1788","article-title":"In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone.","volume":"36","author":"Agger","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","first-page":"945","article-title":"The value of early treatment of deer tick bites for the prevention of Lyme disease.","volume":"147","author":"Agre","year":"1993","journal-title":"Am. J. Dis. Child."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930287","article-title":"Sciatic\u2013vagal nerve stimulation by electroacupuncture alleviates inflammatory arthritis in lyme disease-susceptible C3H mice.","volume":"13","author":"Akoolo","year":"2022","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s12325-023-02435-y","article-title":"Tetracycline-, doxycycline-, minocycline-induced pseudotumor cerebri and esophageal perforation.","volume":"40","author":"Angelette","year":"2023","journal-title":"Adv. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s1074-7613(02)00325-4","article-title":"Salp15, an Ixodes scapularis salivary protein, inhibits CD4+ T cell activation.","volume":"16","author":"Anguita","year":"2002","journal-title":"Immunity"},{"key":"B8","first-page":"916","article-title":"Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.","volume":"111","author":"Arnez","year":"1999","journal-title":"Wiener Klin. Wochenschrift"},{"key":"B9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: A prospective clinical cohort study.","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijid.2022.01.033","article-title":"Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.","volume":"116","author":"Aucott","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjmed.2021.06.051","article-title":"Guidelines for Lyme disease are updated.","volume":"134","author":"Auwaerter","year":"2021","journal-title":"Am. J. Med."},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.4065\/81.9.1263","article-title":"Efficacy of acupuncture vs placebo.","volume":"81","author":"Bartecchi","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment lyme syndrome and central sensitization.","volume":"25","author":"Batheja","year":"2013","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to Lyme disease.","volume":"374","author":"Berende","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","article-title":"An epidemiologic study of Lyme disease in southern Sweden.","volume":"333","author":"Berglund","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis.","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand. J. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.666554","article-title":"Recent progress in Lyme disease and remaining challenges.","volume":"8","author":"Bobe","year":"2021","journal-title":"Front. Med."},{"key":"B18","author":"Bockenstedt","year":"2014","journal-title":"Editorial commentary: Xenodiagnosis for posttreatment Lyme disease syndrome: Resolving the conundrum or adding to it?."},{"key":"B19","first-page":"1136","article-title":"Macrolide therapy of chronic Lyme disease.","volume":"9111","author":"Boston","year":"2003","journal-title":"Signature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1016\/j.vaccine.2005.02.006","article-title":"Multicomponent Lyme vaccine: Three is not a crowd.","volume":"23","author":"Brown","year":"2005","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2018.0105","article-title":"Mice against ticks: An experimental community-guided effort to prevent tick-borne disease by altering the shared environment.","volume":"374","author":"Buchthal","year":"2019","journal-title":"Philos. Trans. R. Soc. B"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0434","article-title":"The Jarisch\u2013Herxheimer reaction after antibiotic treatment of spirochetal infections: A review of recent cases and our understanding of pathogenesis.","volume":"96","author":"Butler","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinte.1990.00040031677015","article-title":"Ceftriaxone therapy of chronic inflammatory arthritis.","volume":"150","author":"Caperton","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"B24","year":"2019","journal-title":"Lyme disease data and surveillance."},{"key":"B25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease.","volume":"123","author":"Cerar","year":"2010","journal-title":"Am. J. Med."},{"key":"B26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1471-2180-13-295","article-title":"Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti","volume":"13","author":"Chan","year":"2013","journal-title":"BMC Microbiol."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9090678","article-title":"Evaluation of nucleoside analogs as antimicrobials targeting unique enzymes in borrelia burgdorferi.","volume":"9","author":"Chakraborti","year":"2020","journal-title":"Pathogens"},{"key":"B29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jpids\/piy067","article-title":"Symptom resolution in pediatric patients with Lyme disease.","volume":"8","author":"Chason","year":"2019","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"B30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853899609033125","article-title":"Lyme neuroborreliosis in children.","volume":"28","author":"Christen","year":"1996","journal-title":"Ann. Med."},{"key":"B31","article-title":"Phase 2 study Of VLA15, A vaccine candidate against lyme borreliosis, in a healthy pediatric and adult study population [Online]","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1603\/033.046.0537","article-title":"Prevention of Lyme disease.","volume":"105","year":"2000","journal-title":"Pediatrics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis.","volume":"9","author":"Comstedt","year":"2014","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1016\/j.vaccine.2015.07.095","article-title":"Characterization and optimization of a novel vaccine for protection against Lyme borreliosis.","volume":"33","author":"Comstedt","year":"2015","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.","volume":"12","author":"Comstedt","year":"2017","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/applmicrobiol3020022","article-title":"An in-depth review of the benefits of antibiotic use in the treatment of Borreliosis in pregnancy.","volume":"3","author":"Cook","year":"2023","journal-title":"Appl. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2019.129455","article-title":"Characterization of 5\u2032-methylthioadenosine\/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.","volume":"1864","author":"Cornell","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jac\/dkp129","article-title":"Assessment of methylthioadenosine\/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.","volume":"63","author":"Cornell","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/infdis\/159.1.136","article-title":"A prospective study of tick bites in an endemic area for Lyme disease.","volume":"159","author":"Costello","year":"1989","journal-title":"J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11908-017-0582-9","article-title":"Management of Lyme disease in European children: A review for practical purpose.","volume":"19","author":"D\u2019Alessandro","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001205","article-title":"Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the Lyme disease agent.","volume":"6","author":"Dai","year":"2010","journal-title":"PLoS Pathog."},{"key":"B42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.chom.2009.10.006","article-title":"Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent.","volume":"6","author":"Dai","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B43","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/155.6.1322","article-title":"Ceftriaxone as effective therapy in refractory Lyme disease","volume":"155","author":"Dattwyler","year":"1987","journal-title":"J. Infect. Dis"},{"key":"B44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0753-3322(89)90240-0","article-title":"Antibiotic treatment of Lyme borreliosis","volume":"43","author":"Dattwyler","year":"1989","journal-title":"Biomed. Pharmacother"},{"key":"B45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis\u2014randomised comparison of ceftriaxone and penicillin","volume":"331","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/17843286.2016.1180829","article-title":"Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of \u2018chronic Lyme disease\u2019.","volume":"72","author":"De Wilde","year":"2017","journal-title":"Acta Clin. Belg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41564-021-01003-w","article-title":"The unusual cell wall of the Lyme disease spirochaete Borrelia burgdorferi is shaped by a tick sugar.","volume":"6","author":"DeHart","year":"2021","journal-title":"Nat. Microbiol."},{"key":"B49","first-page":"297","article-title":"Diagnosis of Lyme disease.","volume":"72","author":"Depietropaolo","year":"2005","journal-title":"Am. Fam. Phys."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/ene.12744","article-title":"Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis\u2013a systematic review.","volume":"22","author":"Dersch","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: A systematic review.","volume":"263","author":"Dersch","year":"2016","journal-title":"J. Neurol."},{"key":"B52","author":"Dhakal","year":"2020","journal-title":"Jarisch herxheimer reaction: StatPearls [Internet]."},{"key":"B53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of Lyme disease.","volume":"167","author":"Dressler","year":"1993","journal-title":"J. Infect. Dis."},{"key":"B54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","article-title":"European neuroborreliosis: Quality of life 30 months after treatment.","volume":"124","author":"Eikeland","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"B55","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","article-title":"Risk factors for a non-favorable outcome after treated E uropean neuroborreliosis.","volume":"127","author":"Eikeland","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2021.101649","article-title":"Control of ixodid ticks and prevention of tick-borne diseases in the United States: The prospect of a new Lyme disease vaccine and the continuing problem with tick exposure on residential properties.","volume":"12","author":"Eisen","year":"2021","journal-title":"Ticks Tick Borne Dis."},{"key":"B57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1473-3099(22)00581-3","article-title":"Erythema migrans: Lyme disease does not need prolonged therapy.","volume":"23","author":"Eldin","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.cmi.2018.02.028","article-title":"Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.","volume":"24","author":"Eliassen","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1542\/peds.109.6.1173","article-title":"Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease.","volume":"109","author":"Eppes","year":"2002","journal-title":"Pediatrics"},{"key":"B61","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.151.11.1571","article-title":"Lyme disease: A neuropsychiatric illness.","volume":"151","author":"Fallon","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"B62","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"B63","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic Lyme disease\u201d.","volume":"357","author":"Feder","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2015.31","article-title":"Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.","volume":"4","author":"Feng","year":"","journal-title":"Emerg. Microbes Infect."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117207","article-title":"Drug combinations against Borrelia burgdorferi persisters in vitro: Eradication achieved by using daptomycin, cefoperazone and doxycycline.","volume":"10","author":"Feng","year":"","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2014.53","article-title":"Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.","volume":"3","author":"Feng","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"B67","first-page":"982","article-title":"Notes from the field: Update on Lyme carditis, groups at high risk, and frequency of associated sudden cardiac death\u2013United States.","volume":"63","author":"Forrester","year":"2014","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/cid\/ciy329","article-title":"Adverse events associated with antibiotics and intravenous therapies for post\u2013Lyme disease syndrome in a commercially insured sample.","volume":"67","author":"Goodlet","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1540-8167.1997.tb00795.x","article-title":"Lyme myocarditis presenting as fascicular tachycardia with underlying complete heart block.","volume":"8","author":"Greenberg","year":"1997","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e002047","DOI":"10.1128\/mBio.02047-17","article-title":"Peptide uptake is essential for Borrelia burgdorferi viability and involves structural and regulatory complexity of its oligopeptide transporter.","volume":"8","author":"Groshong","year":"2017","journal-title":"MBio"},{"key":"B71","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.arcped.2019.02.010","article-title":"Lyme neuroborreliosis in children: Report of nine cases and a review of the literature","volume":"26","author":"Guet-Revillet","year":"2019","journal-title":"Arch. P\u00e9diatr"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e00835","DOI":"10.1128\/msystems.00835-23","article-title":"Metabolic modeling predicts unique drug targets in Borrelia burgdorferi.","volume":"8","author":"Gwynne","year":"2023","journal-title":"Msystems"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S1473-3099(23)00312-2","article-title":"VLA15, a new global Lyme disease vaccine undergoes clinical trials.","volume":"23","author":"Hajdusek","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"B74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/brain\/115.2.399","article-title":"The clinical and epidemiological profile of lyme neuroborreliosis in Denmark 1985\u20131990: A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production.","volume":"115","author":"Hansen","year":"1992","journal-title":"Brain"},{"key":"B76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF01644175","article-title":"Cefotaxime versus penicillin in the late stage of Lyme disease\u2013prospective, randomized therapeutic study.","volume":"18","author":"Hassler","year":"1990","journal-title":"Infection"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1002\/eji.200737034","article-title":"A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.","volume":"37","author":"Hawn","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"B78","first-page":"599","author":"Hercogov\u00e1","year":"2023","journal-title":"Lyme borreliosis: European handbook of dermatological treatments."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study.","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"B80","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/1742395320983875","article-title":"Illness perceptions, coping, and health-related quality of life among individuals experiencing chronic Lyme disease.","volume":"18","author":"Hill","year":"2022","journal-title":"Chron. Illness"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.560018","article-title":"Risk factors and outcomes of treatment delays in Lyme disease: A population-based retrospective cohort study.","volume":"7","author":"Hirsch","year":"2020","journal-title":"Front. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice.","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086907","article-title":"Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.","volume":"9","author":"Hodzic","year":"2014","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040031","article-title":"Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization.","volume":"4","author":"Hovius","year":"2008","journal-title":"PLoS Pathog."},{"key":"B85","author":"Hu","year":"2013","journal-title":"Treatment of Lyme disease."},{"key":"B86","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1128\/AAC.48.1.344-347.2004","article-title":"Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi.","volume":"48","author":"Hunfeld","year":"2004","journal-title":"Antimicrob. Agents chemother."},{"key":"B87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","article-title":"Increased IFN\u03b1 activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.","volume":"255","author":"Jacek","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF00920571","article-title":"Variable CSF findings in early and late Lyme neuroborreliosis: A follow-up study in 47 patients.","volume":"242","author":"Kaiser","year":"1994","journal-title":"J. Neurol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00115-003-1560-z","article-title":"Verlauf der akuten und chronischen Neuroborreliose nach Behandlung mit Ceftriaxon.","volume":"6","author":"Kaiser","year":"2004","journal-title":"Der. Nervenarzt"},{"key":"B91","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0183-8","article-title":"Design of a broadly reactive Lyme disease vaccine.","volume":"5","author":"Kamp","year":"2020","journal-title":"NPJ Vaccines"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease Do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jdcr.2022.11.023","article-title":"A case of Lyme disease complicated by the Jarisch-Herxheimer reaction and coinfection with Babesia.","volume":"32","author":"Karim","year":"2023","journal-title":"JAAD Case Rep."},{"key":"B94","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.amjmed.2013.02.014","article-title":"Treatment trials for post-Lyme disease symptoms revisited.","volume":"126","author":"Klempner","year":"2013","journal-title":"Am. J. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/cid\/cix568","article-title":"Characteristics and clinical outcome of Lyme neuroborreliosis in a high endemic area, 1995\u20132014: A retrospective cohort study in Denmark.","volume":"65","author":"Knudtzen","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B98","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis\u2014epidemiology, diagnosis and management.","volume":"11","author":"Koedel","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"B99","first-page":"209","article-title":"DEET-based insect repellents: Safety implications for children and pregnant and lactating women.","volume":"169","author":"Koren","year":"2003","journal-title":"CMAJ"},{"key":"B100","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1086\/649920","article-title":"Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme disease\u2013hyperendemic area.","volume":"50","author":"Kowalski","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B101","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1161\/CIRCULATIONAHA.112.101485","article-title":"Lyme disease and the heart.","volume":"127","author":"Krause","year":"2013","journal-title":"Circulation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.wnl.0000071227.23769.9e","article-title":"Study and treatment of post Lyme disease (STOP-LD) A randomized double masked clinical trial.","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"B103","article-title":"Lyme borreliosis: Diagnosis and management.","volume":"369","author":"Kullberg","year":"2020","journal-title":"BMJ"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx254","article-title":"Risk factors for clinician-diagnosed Lyme arthritis, facial palsy, carditis, and meningitis in patients from high-incidence states.","volume":"5","author":"Kwit","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"B105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/41.suppl_2.37","article-title":"Anti-inflammatory activity of macrolides: A new therapeutic potential?","volume":"41","author":"Labro","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"B106","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1016\/j.ijid.2009.07.019","article-title":"Maternal Lyme borreliosis and pregnancy outcome.","volume":"14","author":"Lakos","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/s0140-6736(75)92249-7","article-title":"Infantile chronic relapsing inflammation of the brain, skin, and joints.","volume":"305","author":"Lampert","year":"1975","journal-title":"Lancet"},{"key":"B108","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the infectious diseases society of America (IDSA), American academy of neurology (AAN), and American college of rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease.","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ajcp\/aqz030","article-title":"Laboratory blood-based testing for Lyme disease at a national reference laboratory: A 7-year experience (2010-2016).","volume":"152","author":"Lee-Lewandrowski","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"B110","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.cell.2021.09.011","article-title":"A selective antibiotic for Lyme disease.","volume":"184","author":"Leimer","year":"2021","journal-title":"Cell"},{"key":"B111","article-title":"Principles of combination therapy.","volume":"51","author":"Levin","year":"1975","journal-title":"Bull. N. Y. Acad. Med."},{"key":"B112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease.","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors.","volume":"17","author":"Lj\u00f8stad","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: A multicentre, non-inferiority, double-blind, randomised trial.","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol."},{"key":"B115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/AAC.39.3.661","article-title":"Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans.","volume":"39","author":"Luger","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"B116","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cell.2014.02.050","article-title":"Molecular mechanisms underlying bacterial persisters.","volume":"157","author":"Maisonneuve","year":"2014","journal-title":"Cell"},{"key":"B117","article-title":"Post-treatment Lyme disease syndrome: Need for diagnosis and treatment.","volume":"13","author":"Maksimyan","year":"2021","journal-title":"Cureus"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00181","article-title":"Eliminating factor H-binding activity of Borrelia burgdorferi CspZ combined with virus-like particle conjugation enhances its efficacy as a Lyme disease vaccine.","volume":"9","author":"Marcinkiewicz","year":"2018","journal-title":"Front. Immunol."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2020.100079","article-title":"VANGUARD\u00ae crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs.","volume":"6","author":"Marconi","year":"2020","journal-title":"Vaccine X"},{"key":"B120","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1001\/jama.1986.03370240064038","article-title":"Lyme disease during pregnancy.","volume":"255","author":"Markowitz","year":"1986","journal-title":"JAMA"},{"key":"B121","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2007.12.011","article-title":"Chronic Lyme disease: A review.","volume":"22","author":"Marques","year":"2008","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"B122","doi-asserted-by":"publisher","first-page":"607","DOI":"10.15585\/mmwr.mm6623a3","article-title":"Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease\u2014United States.","volume":"66","author":"Marzec","year":"2017","journal-title":"Morb. Mort. Wkly. Rep."},{"key":"B123","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1016\/j.vaccine.2023.06.081","article-title":"Specific mRNA lipid nanoparticles and acquired resistance to ticks.","volume":"41","author":"Matias","year":"2023","journal-title":"Vaccine"},{"key":"B124","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4269\/ajtmh.2001.65.285","article-title":"Safety of the insect repellent N, N-diethyl-M-toluamide (DEET) in pregnancy.","volume":"65","author":"McGready","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B125","first-page":"187","article-title":"Epidemiology of Lyme disease.","volume":"29","author":"Mead","year":"2015","journal-title":"Infect. Dis. Clin."},{"key":"B126","doi-asserted-by":"publisher","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC recommendation for serologic diagnosis of Lyme disease.","volume":"68","author":"Mead","year":"2019","journal-title":"Morb. Mort. Wkly. Rep."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-054980","article-title":"Management of pediatric Lyme disease: Updates from 2020 Lyme guidelines.","volume":"149","author":"Meissner","year":"2022","journal-title":"Pediatrics"},{"key":"B128","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMe1502350","article-title":"Time for a different approach to Lyme disease and long-term symptoms.","volume":"374","author":"Melia","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.micinf.2016.04.002","article-title":"Pleomorphic forms of Borrelia burgdorferi induce distinct immune responses.","volume":"18","author":"Meril\u00e4inen","year":"2016","journal-title":"Microbes Infect."},{"key":"B130","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1172\/JCI72333","article-title":"Antibiotics and the gut microbiota.","volume":"124","author":"Modi","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B131","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion.","volume":"189","author":"Muanda","year":"","journal-title":"CMAJ"},{"key":"B132","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: A population based cohort study.","volume":"83","author":"Muanda","year":"","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B133","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/0128071-200809060-00002","article-title":"Skin manifestations of lyme borreliosis: Diagnosis and management.","volume":"9","author":"Muellegger","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"B135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease.","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite.","volume":"345","author":"Nadelman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.6.563","article-title":"Failure of treatment with cephalexin for Lyme disease.","volume":"9","author":"Nowakowski","year":"2000","journal-title":"Arch. Fam. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0190-9622(95)90130-2","article-title":"Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans.","volume":"32","author":"Nowakowski","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5114\/reum.2020.99143","article-title":"The Jarisch-Herxheimer reaction associated with doxycycline in a patient with Lyme arthritis.","volume":"58","author":"Nykytyuk","year":"2020","journal-title":"Reumatologia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): Clinical and laboratory findings.","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Rev. Infect. Dis."},{"key":"B141","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study.","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B142","doi-asserted-by":"crossref","first-page":"248","DOI":"10.14503\/THIJ-14-4126","article-title":"Sinus pause in association with Lyme carditis.","volume":"42","author":"Oktay","year":"2015","journal-title":"Texas Heart Inst. J."},{"key":"B143","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s004150050216","article-title":"Stages and syndromes of neuroborreliosis.","volume":"245","author":"Oschmann","year":"1998","journal-title":"J. Neurol."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1327416","article-title":"Fibroblast growth factor receptor inhibitors mitigate the neuropathogenicity of Borrelia burgdorferi or its remnants ex vivo.","volume":"15","author":"Parthasarathy","year":"2024","journal-title":"Front. Immunol."},{"key":"B145","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8030117","article-title":"Babesia microti\u2014Borrelia burgdorferi coinfection.","volume":"8","author":"Parveen","year":"2019","journal-title":"Pathogens"},{"key":"B146","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2958.2010.07455.x","article-title":"Methylthioadenosine\/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism.","volume":"79","author":"Parveen","year":"2011","journal-title":"Mol. Microbiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1128\/IAI.74.5.3016-3020.2006","article-title":"Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice.","volume":"74","author":"Parveen","year":"2006","journal-title":"Infect. Immun."},{"key":"B148","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease.","volume":"31","author":"Patel","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-015-4308-1","article-title":"Recent-onset dilated cardiomyopathy associated with Borrelia burgdorferi infection.","volume":"40","author":"Petr Kuchynka","year":"2015","journal-title":"Herz"},{"key":"B150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(94)90130-9","article-title":"Lyme borreliosis: Basic science and clinical aspects.","volume":"343","author":"Pfister","year":"1994","journal-title":"Lancet"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archneur.1989.00520470044025","article-title":"Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis: A prospective randomized study.","volume":"46","author":"Pfister","year":"1989","journal-title":"Arch. Neurol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.","volume":"31","author":"Pine","year":"2023","journal-title":"Mol. Ther."},{"key":"B153","first-page":"285","article-title":"Cardiac manifestations of Lyme disease.","volume":"86","author":"Pinto","year":"2002","journal-title":"Med. Clin."},{"key":"B154","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1099\/ijsem.0.001445","article-title":"Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper Midwestern United States.","volume":"66","author":"Pritt","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: Understanding the dual-host lifestyle of Lyme disease spirochaetes.","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"B156","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/0003-4819-114-6-472","article-title":"Lyme disease: Recommendations for diagnosis and treatment.","volume":"114","author":"Rahn","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"B157","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nature03812","article-title":"The Lyme disease agent exploits a tick protein to infect the mammalian host.","volume":"436","author":"Ramamoorthi","year":"2005","journal-title":"Nature"},{"key":"B158","article-title":"Guidelines for diagnosis and treatment in neurology\u2013Lyme neuroborreliosis.","volume":"18","author":"Rauer","year":"2020","journal-title":"GMS German Med. Sci."},{"key":"B159","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4269\/ajtmh.22-0437","article-title":"Initial presentation and time to treatment in early Lyme disease.","volume":"108","author":"Rebman","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/eurheartj\/12.9.1048","article-title":"Intra-hisian 2: 1 atrioventricular block secondary to Lyme disease.","volume":"12","author":"Rey","year":"1991","journal-title":"Eur. Heart J."},{"key":"B161","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1540-8159.1992.tb06492.x","article-title":"Prospective evaluation of heart block complicating early Lyme disease.","volume":"15","author":"Rubin","year":"1992","journal-title":"Pac. Clin. Electrophysiol."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj9827","article-title":"mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent.","volume":"13","author":"Sajid","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B163","first-page":"137","article-title":"Prevention of Lyme disease after tick bites.","volume":"328","author":"Salzman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"33645","DOI":"10.1074\/jbc.M305799200","article-title":"Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto.","volume":"278","author":"Schr\u00f6der","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.chom.2011.06.010","article-title":"A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent.","volume":"10","author":"Schuijt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B166","doi-asserted-by":"publisher","first-page":"409","DOI":"10.21775\/cimb.042.409","article-title":"Multipartite genome of Lyme disease Borrelia: Structure, variation and prophages.","volume":"42","author":"Schwartz","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease.","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"B168","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1056\/NEJMcp1314325","article-title":"Lyme disease.","volume":"370","author":"Shapiro","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B169","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199212173272501","article-title":"A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites.","volume":"327","author":"Shapiro","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells.","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B171","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/art.27468","article-title":"Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.","volume":"62","author":"Shen","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B172","first-page":"93","article-title":"Lyme disease during pregnancy.","volume":"11","author":"Silver","year":"1997","journal-title":"Infect. Dis. Clin."},{"key":"B173","doi-asserted-by":"publisher","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","article-title":"Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.","volume":"136","author":"Smith","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"B174","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis.","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"B175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3899\/jrheum.190320","article-title":"Treatment of Lyme arthritis.","volume":"46","author":"Steere","year":"2019","journal-title":"J. Rheumatol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1172\/JCI138062","article-title":"Posttreatment Lyme disease syndromes: Distinct pathogenesis caused by maladaptive host responses.","volume":"130","author":"Steere","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B177","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-93-1-8","article-title":"Lyme carditis: Cardiac abnormalities of Lyme disease.","volume":"93","author":"Steere","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJM198504043121401","article-title":"Successful parenteral penicillin therapy of established Lyme arthritis.","volume":"312","author":"Steere","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20052471","article-title":"Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.","volume":"203","author":"Steere","year":"2006","journal-title":"J. Exp. Med."},{"key":"B180","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis.","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum."},{"key":"B181","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis.","volume":"107","author":"Steere","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"B182","first-page":"1","article-title":"Lyme borreliosis.","volume":"2","author":"Steere","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45983-9","article-title":"SCGB1D2 inhibits growth of Borrelia burgdorferi and affects susceptibility to Lyme disease.","volume":"15","author":"Strausz","year":"2024","journal-title":"Nat. Commun."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1086\/653005","article-title":"Long-term outcomes in patients with early Lyme disease: More false hope?","volume":"50","author":"Stricker","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/art.34383","article-title":"Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.","volume":"64","author":"Strle","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B186","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cid\/cit735","article-title":"Elevated levels of IL-23 in a subset of patients with post\u2013Lyme disease symptoms following erythema migrans.","volume":"58","author":"Strle","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/cid\/cix002","article-title":"T-Helper 17 cell cytokine responses in lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory lyme arthritis.","volume":"64","author":"Strle","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B188","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00253-020-10375-8","article-title":"Novel targets and strategies to combat borreliosis.","volume":"104","author":"Strnad","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/s0002-9378(99)70277-2","article-title":"Maternal Lyme disease and congenital heart disease: A case-control study in an endemic area.","volume":"180","author":"Strobino","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"13326","DOI":"10.1074\/jbc.M809575200","article-title":"Acylated cholesteryl galactosides are specific antigens of borrelia causing lyme disease and frequently induce antibodies in late stages of disease.","volume":"284","author":"St\u00fcbs","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261194","article-title":"Association between statin use and clinical course, microbiologic characteristics, and long-term outcome of early Lyme borreliosis. A post hoc analysis of prospective clinical trials of adult patients with erythema migrans.","volume":"16","author":"Stupica","year":"2021","journal-title":"PLoS One"},{"key":"B192","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days.","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B193","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jamainternmed.2024.1754","article-title":"Increasing risk for tick-borne disease: What should clinicians know?","volume":"184","author":"Telford","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/jamadermatol.2018.3186","article-title":"Efficacy and safety of antibiotic therapy in early cutaneous Lyme borreliosis: A network meta-analysis.","volume":"154","author":"Torbahn","year":"2018","journal-title":"JAMA Dermatol."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.816868","article-title":"Case report: Lyme borreliosis and pregnancy-our experience.","volume":"9","author":"Trevisan","year":"2022","journal-title":"Front. Med."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/cid\/ciw599","article-title":"Expression of C-reactive protein and serum amyloid A in early to late manifestations of Lyme disease.","volume":"63","author":"Uhde","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.molmed.2017.10.006","article-title":"Nerve stimulation: Immunomodulation and control of inflammation.","volume":"23","author":"Ulloa","year":"2017","journal-title":"Trends Mol. Med."},{"key":"B198","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/hrt.63.3.162","article-title":"Range of atrioventricular conduction disturbances in Lyme borreliosis: A report of four cases and review of other published reports.","volume":"63","author":"Van der Linde","year":"1990","journal-title":"Heart"},{"key":"B199","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.micinf.2016.03.004","article-title":"Statins reduce spirochetal burden and modulate immune responses in the C3H\/HeN mouse model of Lyme disease.","volume":"18","author":"Van Laar","year":"2016","journal-title":"Microbes Infect."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038171","article-title":"Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi.","volume":"7","author":"Van Laar","year":"2012","journal-title":"PLoS One"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/art.37910","article-title":"Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.","volume":"65","author":"Vudattu","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207067","article-title":"A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn.","volume":"13","author":"Waddell","year":"2018","journal-title":"PLoS One"},{"key":"B203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/vbz.2015.1901","article-title":"An Ixodes ricinus tick salivary lectin pathway inhibitor protects Borrelia burgdorferi sensu lato from human complement.","volume":"16","author":"Wagemakers","year":"2016","journal-title":"Vector Borne Zoonot. Dis."},{"key":"B204","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2147\/DDDT.S77063","article-title":"Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition.","volume":"9","author":"Wagh","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"B205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jpids\/pis078","article-title":"Electrocardiograph abnormalities in children with Lyme meningitis.","volume":"1","author":"Welsh","year":"2012","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"B206","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-3016.1995.tb00148.x","article-title":"Maternal Lyme disease and congenital malformations: A cord blood serosurvey in endemic and control areas.","volume":"9","author":"Williams","year":"1995","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrmicro2536","article-title":"Shifting the balance: Antibiotic effects on host\u2013microbiota mutualism.","volume":"9","author":"Willing","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/cid\/ciw189","article-title":"Long-term follow-up of patients with Lyme disease: Longitudinal analysis of clinical and quality-of-life measures.","volume":"62","author":"Wills","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B209","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12016-021-08906-w","article-title":"A review of post-treatment lyme disease syndrome and chronic lyme disease for the practicing immunologist.","volume":"62","author":"Wong","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diagmicrobio.2018.09.015","article-title":"How safe is doxycycline for young children or for pregnant or breastfeeding women?","volume":"93","author":"Wormser","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.diagmicrobio.2019.01.003","article-title":"Efficacy of a 14-day course of amoxicillin for patients with erythema migrans.","volume":"94","author":"Wormser","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious diseases society of America.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B213","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/314053","article-title":"Practice guidelines for the treatment of Lyme disease.","volume":"31","author":"Wormser","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B214","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease: A randomized, double-blind, placebo-controlled trial.","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.","volume":"75","author":"Wormser","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00464","article-title":"Symptom clusters and functional impairment in individuals treated for Lyme borreliosis.","volume":"7","author":"Zubcevik","year":"2020","journal-title":"Front. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1459202\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:55:52Z","timestamp":1726203352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1459202\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":216,"alternative-id":["10.3389\/fmicb.2024.1459202"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1459202","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"article-number":"1459202"}}